For screening and diagnosis of Parkinson disease (PD), progressive supranuclear palsy (PSP), and multiple system atrophy-parkinsonian/cerebellar subtypes (MSA-P/MSA-C), we propose a two-step decision tree using a novel MRI biomarker and volumetric measures. MRIs from 50 MSA-C, 22 MSA-P, 50 PSP, 50 PD, and 172 age/legal-sex-matched control were used for fully automated volumetric analysis of the brain and brainstem. Sensitivity/specificity for diseased vs control was 90.1/90.7%. Then, a comprehensive tree with the diseased group yielded sensitivity/specificity of 81.9/93.0% (MSA), 94.0/88.5% (MSA-C), 54.5/96.0% (MSA-P), 74.0/86.0% (PD), 76.0/98.4% (PSP). We provide a reproducible and specific diagnostic tool for screening and initial differential diagnosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords